文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

壳寡糖包覆的纳米结构脂质载体及其在眼部药物传递系统中的潜在应用。

Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.

机构信息

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China. bluer

出版信息

Int J Pharm. 2011 Jan 17;403(1-2):185-91. doi: 10.1016/j.ijpharm.2010.10.013. Epub 2010 Oct 15.


DOI:10.1016/j.ijpharm.2010.10.013
PMID:20951778
Abstract

The objective of the present investigation was to explore the potential of the Chitosan Oligosaccharides (COS)-coated NLC (nanostructured lipid carrier) for ocular drug delivery. NLC loaded with flurbiprofen was prepared by melt-ultrasonic method and then coated with COS with a molecular weight of 3000-6000kDa. After coating, the particles reflected spherical morphology with smooth surface under transmission electron microscope (TEM) analysis and a changed zeta potential from -0.446mV to +20.7mV. The ocular bioadhesion property was evaluated by Gamma scintigraphic technique, revealing that the clearance of the formulations labeled with radioactive 99(m)Tc-DTPA was significantly delayed in the presence of COS, and the AUC of the COS-coated formulation had a 7.7-fold increase comparing with non-coated ones. Additionally, enhanced transcorneal penetration was achieved by using the COS coating with a corresponding apparent permeability coefficients (P(app)) which had a 2.4-fold increase comparing with the reference. Consequently, COS coating modified the properties of NLCs and presented a series of notable advantages in ophthalmic application.

摘要

本研究旨在探索壳寡糖(COS)包覆的纳米结构脂质载体(NLC)用于眼部药物传递的潜力。采用熔融超声法制备负载氟比洛芬的 NLC,然后用分子量为 3000-6000kDa 的 COS 进行包覆。包覆后,颗粒在透射电子显微镜(TEM)分析下呈现球形形态,表面光滑,zeta 电位从-0.446mV 变为+20.7mV。通过放射性核素 99(m)Tc-DTPA 标记的制剂的γ闪烁显像技术评估眼部生物黏附特性,结果表明在 COS 的存在下,放射性标记制剂的清除率明显延迟,并且 COS 包覆制剂的 AUC 与非包覆制剂相比增加了 7.7 倍。此外,通过使用 COS 涂层可以实现增强的角膜穿透,相应的表观渗透系数(P(app))增加了 2.4 倍。因此,COS 涂层修饰了 NLC 的性质,并在眼部应用中表现出一系列显著的优势。

相似文献

[1]
Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.

Int J Pharm. 2010-10-15

[2]
Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.

Eur J Pharm Biopharm. 2017-9-1

[3]
A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.

Carbohydr Polym. 2016-3-29

[4]
Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.

Nanotechnology. 2010-12-20

[5]
Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery.

J Pharm Sci. 2011-11-18

[6]
Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.

Int J Pharm. 2009-9-8

[7]
Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.

Sci Rep. 2016-6-28

[8]
Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.

Colloids Surf B Biointerfaces. 2010-7-27

[9]
A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.

Int J Pharm. 2008-11-3

[10]
Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.

Int J Pharm. 2012-9-15

引用本文的文献

[1]
Construction of Chitosan Oligosaccharide-Coated Nanostructured Lipid Carriers for the Sustained Release of Strontium Ranelate.

Tissue Eng Regen Med. 2025-3-12

[2]
Design, synthesis of some novel coumarins and their nanoformulations into lipid-chitosan nanocapsule as unique antimicrobial agents.

Sci Rep. 2024-12-23

[3]
Self-nanoemulsifying drug delivery system for nebulization: fabrication and evaluation for systemic delivery of atorvastatin.

Naunyn Schmiedebergs Arch Pharmacol. 2025-4

[4]
Nanomedicine in glaucoma treatment; Current challenges and future perspectives.

Mater Today Bio. 2024-9-4

[5]
An in vitro study for reducing the cytotoxicity and dose dumping risk of remdesivir via entrapment in nanostructured lipid carriers.

Sci Rep. 2024-8-21

[6]
Advancements in application of chitosan and cyclodextrins in biomedicine and pharmaceutics: recent progress and future trends.

RSC Adv. 2024-4-24

[7]
A Clinical, Pharmacological, and Formulation Evaluation of Melatonin in the Treatment of Ocular Disorders-A Systematic Review.

Int J Mol Sci. 2024-4-3

[8]
Optimized Ribociclib nanostructured lipid carrier for the amelioration of skin cancer: Inferences from skin permeation and dermatokinetic studies.

Saudi Pharm J. 2024-3

[9]
A Direct Comparison of Peptide Drug Delivery Systems Based on the Use of Hybrid Calcium Phosphate/Chitosan Nanoparticles versus Unmixed Calcium Phosphate or Chitosan Nanoparticles In Vitro and In Vivo.

Int J Mol Sci. 2023-10-24

[10]
An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye.

ACS Omega. 2023-9-22

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索